rs886038939

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 5P and 2B. PM1PM2PP2BP4_Moderate

The NM_000090.4(COL3A1):​c.2927T>C​(p.Val976Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000695 in 1,439,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. V976V) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

COL3A1
NM_000090.4 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 0.168

Publications

0 publications found
Variant links:
Genes affected
COL3A1 (HGNC:2201): (collagen type III alpha 1 chain) This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome type IV, and with aortic and arterial aneurysms. [provided by R. Dalgleish, Feb 2008]
COL3A1 Gene-Disease associations (from GenCC):
  • autosomal dominant Ehlers-Danlos syndrome, vascular type
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • Ehlers-Danlos syndrome, vascular type
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polymicrogyria with or without vascular-type Ehlers-Danlos syndrome
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_000090.4
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the COL3A1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 495 curated pathogenic missense variants (we use a threshold of 10). The gene has 19 curated benign missense variants. Gene score misZ: 4.0879 (above the threshold of 3.09). Trascript score misZ: 4.5995 (above the threshold of 3.09). GenCC associations: The gene is linked to Ehlers-Danlos syndrome, vascular type, polymicrogyria with or without vascular-type Ehlers-Danlos syndrome, autosomal dominant Ehlers-Danlos syndrome, vascular type.
BP4
Computational evidence support a benign effect (MetaRNN=0.21486607).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL3A1NM_000090.4 linkc.2927T>C p.Val976Ala missense_variant Exon 40 of 51 ENST00000304636.9 NP_000081.2 P02461-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL3A1ENST00000304636.9 linkc.2927T>C p.Val976Ala missense_variant Exon 40 of 51 1 NM_000090.4 ENSP00000304408.4 P02461-1
COL3A1ENST00000450867.2 linkc.2828T>C p.Val943Ala missense_variant Exon 39 of 50 1 ENSP00000415346.2 H7C435
COL3A1ENST00000713745.1 linkc.2774T>C p.Val925Ala missense_variant Exon 38 of 49 ENSP00000519049.1
COL3A1ENST00000713744.1 linkc.2927T>C p.Val976Ala missense_variant Exon 40 of 49 ENSP00000519048.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.95e-7
AC:
1
AN:
1439020
Hom.:
0
Cov.:
32
AF XY:
0.00000140
AC XY:
1
AN XY:
713256
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33380
American (AMR)
AF:
0.00
AC:
0
AN:
40912
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25452
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39140
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82220
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52158
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5642
European-Non Finnish (NFE)
AF:
9.09e-7
AC:
1
AN:
1100546
Other (OTH)
AF:
0.00
AC:
0
AN:
59570
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial thoracic aortic aneurysm and aortic dissection Uncertain:2
Aug 08, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2927T>C (p.V976A) alteration is located in exon 40 (coding exon 40) of the COL3A1 gene. This alteration results from a T to C substitution at nucleotide position 2927, causing the valine (V) at amino acid position 976 to be replaced by an alanine (A). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration was identified in a patient who presented with spontaneous coronary artery dissection (SCAD) and was included in a study to evaluate clinical features, family history, and genes associated with SCAD (Kaadan, 2018). This amino acid position is poorly conserved in available vertebrate species, and alanine is the reference amino acid in other vertebrate species. This alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Jun 04, 2024
Color Diagnostics, LLC DBA Color Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This missense variant replaces valine with alanine at codon 976 of the COL3A1 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with spontaneous coronary artery dissection (PMID: 29650765) and in one individual affected with cardiomyopathy (PMID: 32009526). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Ehlers-Danlos syndrome, type 4;C5193040:Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome Uncertain:1
Sep 22, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, type 4 Uncertain:1
Jul 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 976 of the COL3A1 protein (p.Val976Ala). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with spontaneous coronary artery dissection or cardiomyopathy (PMID: 29650765, 32009526). ClinVar contains an entry for this variant (Variation ID: 263828). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COL3A1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.078
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
13
DANN
Benign
0.83
DEOGEN2
Benign
0.39
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.025
N
LIST_S2
Benign
0.85
T
M_CAP
Uncertain
0.29
D
MetaRNN
Benign
0.21
T
MetaSVM
Benign
-0.33
T
MutationAssessor
Benign
0.25
N
PhyloP100
0.17
PrimateAI
Benign
0.38
T
PROVEAN
Benign
0.33
N
REVEL
Benign
0.23
Sift
Benign
0.55
T
Sift4G
Benign
0.63
T
Polyphen
0.19
B
Vest4
0.20
MutPred
0.24
Loss of ubiquitination at K977 (P = 0.1055);
MVP
0.59
MPC
1.6
ClinPred
0.16
T
GERP RS
-0.23
Varity_R
0.051
gMVP
0.44
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs886038939; hg19: chr2-189869086; API